A detailed history of Sawtooth Solutions, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sawtooth Solutions, LLC holds 21,841 shares of GILD stock, worth $2.05 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
21,841
Previous 20,012 9.14%
Holding current value
$2.05 Million
Previous $1.5 Million 18.01%
% of portfolio
0.05%
Previous 0.05%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

BUY
$73.27 - $83.09 $134,010 - $151,971
1,829 Added 9.14%
21,841 $1.77 Million
Q3 2023

Oct 19, 2023

SELL
$73.94 - $80.67 $222,633 - $242,897
-3,011 Reduced 13.08%
20,012 $1.5 Million
Q2 2023

Jul 26, 2023

SELL
$76.01 - $86.7 $429,760 - $490,201
-5,654 Reduced 19.72%
23,023 $1.77 Million
Q1 2023

Apr 27, 2023

BUY
$77.31 - $88.08 $1.16 Million - $1.32 Million
14,956 Added 109.0%
28,677 $2.38 Million
Q4 2022

Feb 02, 2023

SELL
$62.32 - $89.47 $59,204 - $84,996
-950 Reduced 6.48%
13,721 $1.18 Million
Q3 2022

Oct 12, 2022

BUY
$59.54 - $68.01 $203,031 - $231,914
3,410 Added 30.28%
14,671 $905,000
Q2 2022

Jul 19, 2022

SELL
$57.72 - $65.01 $240,230 - $270,571
-4,162 Reduced 26.99%
11,261 $696,000
Q1 2022

May 20, 2022

SELL
$57.92 - $72.58 $512,534 - $642,260
-8,849 Reduced 36.46%
15,423 $916,000
Q4 2021

Feb 11, 2022

BUY
$64.88 - $73.64 $544,797 - $618,355
8,397 Added 52.89%
24,272 $1.76 Million
Q3 2021

Nov 09, 2021

BUY
$67.69 - $73.03 $136,259 - $147,009
2,013 Added 14.52%
15,875 $1.11 Million
Q2 2021

Sep 01, 2021

BUY
$63.47 - $69.35 $143,124 - $156,384
2,255 Added 19.43%
13,862 $955,000
Q1 2021

May 13, 2021

SELL
$60.0 - $68.46 $1.08 Million - $1.23 Million
-17,999 Reduced 60.8%
11,607 $750,000
Q4 2020

Feb 09, 2021

BUY
$56.65 - $64.55 $9,064 - $10,328
160 Added 0.54%
29,606 $1.73 Million
Q3 2020

Nov 04, 2020

BUY
$62.1 - $78.08 $98,863 - $124,303
1,592 Added 5.72%
29,446 $1.86 Million
Q2 2020

Aug 06, 2020

SELL
$72.34 - $84.0 $1.06 Million - $1.23 Million
-14,639 Reduced 34.45%
27,854 $2.14 Million
Q1 2020

May 15, 2020

BUY
$62.63 - $80.22 $50,417 - $64,577
805 Added 1.93%
42,493 $3.18 Million
Q4 2019

Feb 12, 2020

BUY
$61.62 - $67.78 $41,716 - $45,887
677 Added 1.65%
41,688 $2.71 Million
Q3 2019

Nov 07, 2019

BUY
$62.51 - $69.0 $984,907 - $1.09 Million
15,756 Added 62.39%
41,011 $2.6 Million
Q2 2019

Aug 08, 2019

BUY
$61.87 - $69.38 $1.2 Million - $1.35 Million
19,467 Added 336.33%
25,255 $1.71 Million
Q1 2019

May 10, 2019

SELL
$62.53 - $70.05 $94,545 - $105,915
-1,512 Reduced 20.71%
5,788 $376,000
Q4 2018

Feb 13, 2019

BUY
$60.54 - $79.0 $280,058 - $365,454
4,626 Added 173.0%
7,300 $457,000
Q3 2018

Oct 26, 2018

SELL
$71.28 - $78.92 $914,094 - $1.01 Million
-12,824 Reduced 82.75%
2,674 $206,000
Q2 2018

Aug 10, 2018

BUY
$64.88 - $75.68 $139,946 - $163,241
2,157 Added 16.17%
15,498 $1.1 Million
Q1 2018

May 08, 2018

SELL
$72.84 - $88.8 $33,724 - $41,114
-463 Reduced 3.35%
13,341 $1.01 Million
Q4 2017

Feb 13, 2018

BUY
$71.15 - $83.52 $982,154 - $1.15 Million
13,804
13,804 $989,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Sawtooth Solutions, LLC Portfolio

Follow Sawtooth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.